Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sleep Apnea, Obstructive 1Sarcoma 1Rhinitis, Allergic, Seasonal 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Mesothelioma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Kidney Neoplasms 1Hypertension, Pulmonary 1Emphysema 1Cystic Fibrosis 1Bronchiectasis 1Breast Neoplasms 1Asthma 1Asbestosis 1

Interventions

aldesleukin 2Interleukin-2 2perflutren 1denileukin diftitox 1Sorafenib 1Oncolytic Virotherapy 1Microscopy, Electron 1Isoflavones 1Genistein 1CYT-6091 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Kidney Neoplasms × perflutren × Clear all
NCT01751529 2017-03-17

Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
48 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡